Introduction {#s1}
============

Exposures to airborne particulate matter (PM) $\leq 10$, $\leq 2.5$ and between 2.5 and $10\;\mu m$ in diameter (${PM}_{10}$, ${PM}_{2.5}$, and ${PM}_{2.5–10}$, respectively) can trigger inflammatory responses that involve the release and hematogenous redistribution of leukocytes ([@c76]; [@c92]; [@c94]). Such responses may be key to the pathophysiology underpinning established associations between ambient PM, cardiovascular (CVD) disease risk, and mortality ([@c13]; [@c18]; [@c25]; [@c61]; [@c71]). However, evidence of PM-associated leukocytosis is inconsistent and mostly based on small studies and panels with limited generalizability ([@c14]; [@c29]; [@c32]; [@c35]; [@c36]; [@c46]; [@c47]; [@c63], [@c62]; [@c77], [@c76]; [@c78]; [@c83]; [@c88]; [@c96]).

In larger, community- and population-based studies, short-duration ${PM}_{10}$--leukocyte count associations are similarly inconsistent ([@c54]; [@c85]; [@c87]; [@c89]), although longer-duration ${PM}_{10}$-- and ${PM}_{2.5}$--leukocyte count associations tend to be positive in published cross-sectional and longitudinal studies ([@c17]; [@c20]; [@c102]). Moreover, associations between short- and longer-term PM exposures and leukocyte count and its differential composition have not been thoroughly evaluated while controlling for known relationships among leukocyte traits (count and component proportions).

Associations between ambient PM exposures and leukocyte traits could nevertheless lend support to the hypothesized role of inflammation in PM-related pathogenesis. Furthermore, their magnitude would provide insight into PM associations with leukocyte-derived biomarkers such as DNA methylation (DNAm), a heritable but dynamic epigenetic modification that can influence gene expression. Indeed, epidemiologic studies often rely on peripheral blood leukocytes as a source of DNA for DNAm assays given the relative ease with which they are collected and archived in large populations ([@c60]; [@c111]). Because DNAm and other epigenetic biomarkers ([@c8]) differ among leukocyte subtypes \[e.g., granulocytes vs. monocytes ([@c43]; [@c48])\], leukocyte composition may plausibly mediate their associations with environmental exposures.

To expand on prior work evaluating PM--leukocyte count associations, and to address the limitations of studies examining PM--leukocyte compositional associations, we estimated associations of leukocyte traits with short- to longer-duration exposures to ambient ${PM}_{2.5}$, ${PM}_{10}$, and ${PM}_{2.5–10}$ in large, multiracial/ethnic, and geographically diverse United States populations enrolled in the Women's Health Initiative (WHI) and the Atherosclerosis Risk in Communities (ARIC) study.

Methods {#s2}
=======

Study Populations {#s2.1}
-----------------

The WHI is a multicenter prospective study of risk factors for CVD, breast/colorectal cancer, and osteoporotic fractures ([@c106], [@c3]). From forty clinical centers throughout the United States, postmenopausal women aged 50--79 years of age were either randomized in the Clinical Trials (CT; $n = 68,132$) or enrolled in the Observational Study (OS; $n = 93,676$) between 1993 and 1998. The WHI CT included three interventions: *a*) hormone therapy (i.e., estrogen with or without progestin vs. placebo), *b*) calcium and vitamin D supplementation (vs. placebo), and *c*) dietary modification (vs. usual diet). The WHI OS ([@c106], [@c3]) recruited participants interested in the dietary modification or hormone therapy trials of the WHI CT but were otherwise ineligible, unwilling, or unresponsive to a direct invitation.

The WHI CT and OS participants completed a baseline screening visit, at which fasting blood and other demographic, socioeconomic, behavioral, and medical information was collected by trained and certified staff. The present study additionally included WHI CT participant data from triennial follow-up visits 3 and 6 y after randomization (Annual Visits 3 and 6) and WHI OS participant data 3 y after enrollment (Annual Visit 3), at which fasting blood was redrawn.

The ARIC study is a prospective epidemiologic study of atherosclerosis and CVD in four U.S. communities: Washington County, Maryland; Forsyth County, North Carolina; selected suburbs of Minneapolis, Minnesota; and Jackson, Mississippi ([@c4]). Participants were selected as a community-stratified probability sample of 15,792 mostly African- and European-American men and women 45--64 years of age and participated in a baseline exam (Visit 1; 1987--1989) at which fasting blood and other demographic, socioeconomic, behavioral, and medical information was collected by trained and certified staff. The present study also included participant data from up to three triennial follow-up visits 3, 6, and 9 y after enrollment (Visits 2--4, 1990--1998) during which fasting blood was redrawn.

Leukocyte composition analyses were conducted in five WHI and ARIC subpopulations with available DNAm data (see Table S1). The three WHI subpopulations included *a*) Ancillary Study 315 (WHI-EMPC; $n = 2,200$) ([@c103]), *b*) Broad Agency Announcement 23 (WHI-BAA23; $n = 1,988$) ([@c5]), and *c*) Ancillary Study 311 (WHI-AS311; $n = 860$) ([@c10]). WHI-EMPC, also known as Epigenetic Mechanisms of PM-Mediated CVD Risk, is a study of epigenetic mechanisms underlying associations between PM and CVD within randomly selected WHI CT participants at the screening visit, Annual Visit 3, or Annual Visit 6. WHI-BAA23, also known as Integrative Genomics and Risk of CHD and Related Phenotypes in the Women's Health Initiative, is a case--control study of coronary heart disease. By design, WHI-BAA23 oversampled African Americans and Hispanic/Latino Americans and required all participants to have undergone genome-wide genotyping and profiling of seven CVD biomarkers. DNAm was measured in blood collected at the screening visit, before the incidence of coronary heart disease. WHI-AS311, also known as the Bladder Cancer and Leukocyte Methylation study, is a nested case--control study of bladder cancer. Bladder cancer cases were matched to controls based on enrollment year, age at enrollment, follow-up time, and DNAm extraction method. DNAm was measured in blood collected at the screening visit, before the incidence of bladder cancer. The two ARIC subpopulations included 2,796 African Americans from Forsyth County or Jackson (ARIC-AA) with DNA and 1,139 European Americans from Forsyth County, Minneapolis, or Washington County (ARIC-EA) with cerebral magnetic resonance imaging data ([@c64]) all at Visits 2 (1990--1992) or 3 (1993--1995) (see Figure S1).

Leukocyte Counts and Composition {#s2.2}
--------------------------------

Leukocyte counts were measured among WHI CT participants at the screening visit, among OS participants at the screening visit and Annual Visit 3, and among ARIC participants at Visits 1--2 on automated cell counters at local laboratories following standard quality assurance procedures ([@c70]). Leukocyte counts were remeasured among ARIC participants in Washington County at Visits 3--4 and in Forsyth County at Visit 4. [Table 1](#t1){ref-type="table"} displays the number of included participants with leukocyte count data, by study and visit. Established associations between leukocyte count, demographic, and clinical variables in WHI and ARIC have been reported by others ([@c59]; [@c67]).

###### 

Characteristics of $n = 165,675$ participants with leukocyte count data before imputation, Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1986--1998) study.

Table 1 has nine columns. The first column lists characteristics. The adjacent columns list WHI screening visit and ARIC visit (n equals 159,162); WHI screening visit (n equals 144,744); WHI annual visit 3 (n equals 77,096); ARIC visit 1 (n equals 14,418); ARIC visit 2 (n equals 13,000); ARIC visit 3 (n equals 3,100); ARIC visit 4 (n equals 5,433); and WHI and ARIC percentage imputed of 285,548 observations.

  Characteristic                                                           WHI screening visit and ARIC visit 1 $n = 159,162$   WHI                 ARIC                WHI and ARIC                                                                                                                                                    
  ------------------------------------------------------------------------ ---------------------------------------------------- ------------------- ------------------- --------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- -----
  Male \[*n* (%)\]                                                         6,563 (4.1)                                          0 (0.0)             0 (0.0)             6,563 (45.5)                            5,892 (45.3)                            1,470 (47.4)                            2,497 (46.0)                            0
  Age \[y ($\text{mean} \pm \text{SD}$)\]                                  $62.3 \pm 7.6$                                       $63.2 \pm 7.2$      $66.5 \pm 7.3$      $54.2 \pm 5.8$                          $57.0 \pm 5.7$                          $60.6 \pm 5.6$                          $63.3 \pm 5.7$                          0
  Race/ethnicity \[*n* (%)\]                                                                                                                                                                                                                                                                                                            0.2
   American Indian or Alaskan Native                                       658 (0.4)                                            647 (0.4)           315 (0.4)           11 (0.1)                                10 (0.1)                                2 (0.1)                                 5 (0.1)                                 
   Asian or Pacific islander                                               1,633 (1.0)                                          1,601 (1.1)         1,018 (1.3)         32 (0.2)                                29 (0.2)                                9 (0.3)                                 16 (0.3)                                
   Black or African American                                               15,809 (10.0)                                        11,990 (8.3)        5,675 (7.4)         3,819 (26.5)                            3,221 (24.8)                            25 (0.8)                                244 (4.5)                               
   Hispanic/Latino                                                         5,967 (3.8)                                          5,967 (4.1)         2,681 (3.5)         ---[^*d*^](#TF5){ref-type="table-fn"}   ---[^*d*^](#TF5){ref-type="table-fn"}   ---[^*d*^](#TF5){ref-type="table-fn"}   ---[^*d*^](#TF5){ref-type="table-fn"}   
   Other                                                                   1,353 (0.9)                                          1,353 (0.9)         740 (1.0)           0 (0.0)                                 0 (0.0)                                 0 (0.0)                                 0 (0.0)                                 
   White (not of Hispanic origin) or European American                     133,400 (84.0)                                       122,844 (85.1)      66,457 (86.4)       10,556 (73.2)                           9,740 (74.9)                            3,064 (98.8)                            5,168 (95.1)                            
  Education \[*n* (%)\]                                                                                                                                                                                                                                                                                                                 0.6
   High school education or lower                                          40,473 (25.6)                                        32,358 (22.5)       15,677 (20.5)       8,115 (56.4)                            7,136 (55.0)                            2,115 (68.3)                            3,148 (58.0)                            
   More than high school                                                   117,654 (74.4)                                       111,377 (77.5)      60,818 (79.5)       6,277 (43.6)                            5,842 (45.0)                            982 (31.7)                              2,279 (42.0)                            
  Smoking status \[*n* (%)\]                                                                                                                                                                                                                                                                                                            2.0
   Never                                                                   78,794 (50.1)                                        72,760 (50.9)       37,749 (51.1)       6,034 (41.9)                            5,173 (39.9)                            1,378 (44.5)                            2,270 (41.9)                            
   Former                                                                  64,941 (41.2)                                        60,314 (42.2)       32,708 (44.2)       4,627 (32.1)                            4,897 (37.7)                            1,259 (40.6)                            2,331 (43.0)                            
   Current                                                                 13,564 (8.6)                                         9,821 (6.9)         3,465 (4.7)         3,743 (26.0)                            2,909 (22.4)                            463 (14.9)                              822 (15.2)                              
  Alcohol use \[*n* (%)\]                                                                                                                                                                                                                                                                                                               1.4
   Never                                                                   18,683 (11.8)                                        15,101 (10.5)       6,807 (9.1)         3,582 (24.9)                            2,917 (22.5)                            783 (25.3)                              1,273 (23.5)                            
   Former                                                                  28,972 (18.3)                                        26,274 (18.3)       15,040 (20.1)       2,698 (18.8)                            2,678 (20.6)                            761 (24.6)                              1,680 (31.0)                            
   Current                                                                 110,366 (69.8)                                       102,289 (71.2)      52,866 (70.8)       8,077 (56.3)                            7,384 (56.9)                            1,554 (50.2)                            2,474 (45.6)                            
  Body mass index \[${{kg}/m}^{2}$ ($\text{mean} \pm \text{SD}$)\]         $28.0 \pm 5.8$                                       $28.9 \pm 5.9$      $27.4 \pm 5.7$      $27.7 \pm 5.3$                          $28.0 \pm 5.4$                          $28.8 \pm 5.5$                          $28.3 \pm 5.4$                          3.2
  Physical activity \[MET-h/week ($\text{mean} \pm \text{SD}$)\]           $12.3 \pm 13.7$                                      $12.5 \pm 13.7$     $13.7 \pm 14.6$     $10.2 \pm 12.7$                         $10.7 \pm 11.5$                         $10.7 \pm 12.9$                         $11.7 \pm 12.9$                         3.6
  Neighborhood SES (*z*-score sum)                                         $- 0.1 \pm 5.4$                                      $- 0.1 \pm 5.4$     0.2 (5.3)           0.0 (5.4)                               $- 0.0$ (5.4)                           $- 0.9$ (2.9)                           0.4 (4.4)                               9.1
  Leukocyte count \[$\text{cells}/\mu L$ ($\text{mean} \pm \text{SD}$)\]   $5,908 \pm 1,553$                                    $5,882 \pm 1,529$   $5,794 \pm 1,500$   $6,076 \pm 1,761$                       $5,952 \pm 1,677$                       $6,435 \pm 1,680$                       $6,394 \pm 1,671$                       3.9

Note: ARIC, Atherosclerosis Risk in Communities; SD, standard deviation; SES, socioeconomic status; WHI, Women's Health Initiative.

WHI Observational Study participants only.

Participants from Washington County only.

Participants from Forsyth County (46%) or Washington County (54%).

ARIC recruitment and data collection occurred before the National Institutes of Health required collection of information about Hispanic/Latino ethnicity.

Leukocyte composition \[i.e., the proportions of $\text{CD}8^{+}$ T cells, ${\text{CD}4}^{+}$ T cells, natural killer (NK) cells, B cells, monocytes, and granulocytes\] were validly estimated ([@c43]) among a subset of WHI and ARIC participants with DNAm data using methods that leverage differentially methylated regions \[i.e., stably methylated CpG sites within, but variably methylated CpG sites among leukocyte cell types ([@c43]; [@c51])\]. Table S2 displays the number of included participants with leukocyte composition data, by subpopulation.

Particulate Matter Exposure Estimation {#s2.3}
--------------------------------------

The study focused on ${PM}_{2.5}$, ${PM}_{10}$, and (coarse) ${PM}_{2.5–10}$, the first two of which are regulated under the Clean Air Act by the U.S. Environmental Protection Agency (EPA) ([@c98]). PM exposures were based on either daily or monthly estimation methods. Daily mean concentrations (in micrograms per cubic meter) of ${PM}_{10}$ were spatially estimated at all geocoded participant addresses ([@c105], [@c104]) using U.S. EPA Air Quality System (AQS) data and national-scale, log-normal ordinary kriging ([@c55], [@c56]). For each participant, daily mean concentrations of ${PM}_{10}$ were averaged over 2 and 7 d prior to and including the day of the study visit.

Geocoded participant address-specific monthly mean concentrations (in micrograms per cubic meter) of ${PM}_{10}$ and ${PM}_{2.5}$ were spatiotemporally estimated using generalized additive mixed models and geographic information system--based predictors. Because U.S. EPA AQS monitoring data for ${PM}_{2.5}$ were not widely available until 1999, spatiotemporal estimation also involved the log-transformed ratio of ${PM}_{2.5}$ to predicted ${PM}_{10}$ between 1987 and 1999 ([@c107]). Monthly mean concentrations were averaged over the 12 months prior to and including examination months to obtain annual means. ${PM}_{2.5–10}$ concentrations for 1- and 12-month means were defined as the monthly differences between ${PM}_{10}$ and ${PM}_{2.5}$ concentrations.

Covariates {#s2.4}
----------

Demographic, socioeconomic, behavioral, and medical covariates included study center, visit, self-identified race/ethnicity, age (in years), individual-level education (high school education or lower, more than high school), neighborhood socioeconomic status ([@c27]), smoking status (current, former, never), alcohol use (current, former, never), measured body mass index (BMI; in kilograms per squared meters), total energy expenditure \[metabolic equivalent of task (MET)-hours/week\], mean temperature (in degrees Celsius), mean dew point (in degrees Celsius), mean barometric pressure (in kilopascals), season (using sine/cosine functions) ([@c90]), and to control for longer-term temporal trends, an interval-scale variable for calendar date. Race/ethnicity and individual-level education were self-reported at baseline. Smoking status, alcohol use, BMI, and total energy expenditure were evaluated at each study visit, the latter based on the type, frequency, and duration of recreational physical activity ([@c58]). When physical activity information was unavailable, it was defined as the value given at the last visit or the weighted mean between visits if data were available. Geocoded participant address-specific neighborhood socioeconomic status was a sum of *Z*-transformed U.S. Census tract-level measures of median household income; percent of households with interest dividends or rent income; percent of population at least 25 years of age with a high school degree; percent of population at least 16 years of age with professional, managerial, or executive occupations; and median value of owner-occupied housing units ([@c27]). Geocoded participant address-specific daily mean temperature, dew point, and barometric pressure were averaged across all National Climatic Data Center monitoring stations within $50\;{km}$ ([@c65]), then averaged over 2, 7, 28, and 365 d prior to and including the day of the study visit.

Subpopulation-specific covariates included sex (in ARIC), randomly assigned treatment group (in WHI), case--control status (in WHI-AS311 and WHI-BAA23), and other sampling-related variables in WHI-AS311 (i.e., enrollment year, age at enrollment, follow-up time, DNAm extraction method).

Exclusions {#s2.5}
----------

Of all observations in WHI and ARIC ($n = 285,548$), small percentages were excluded because they were made on participants in one WHI center outside of the contiguous 48 states (2%), on study visit dates for which PM was not estimable (2%), among participants with a study-specific leukocyte $\text{count} > 99.5\text{th\  \ percentile}$ (leukocytosis, 0.5%), study-specific leukocyte $\text{count} < 0.5\text{th\  \ percentile}$ (leukopenia, 0.5%), or conditions associated with abnormal leukocyte traits such as hematological malignancy (1.7%) or oral/parenteral use of a granulocyte/macrophage colony stimulating factor ($< 0.01\%$), lithium (0.2%), glucocorticosteroid (1.1%), or antibiotic use (2.6%).

Multiple Imputation {#s2.6}
-------------------

To avoid potential for selection bias in complete-data analyses when data are missing at random ([@c42]), multivariate imputation by chained equations (MICE) ([@c6]; [@c91]) was used to impute missing data (percentage missing range: 0.6--9.1%). Binary and categorical data were imputed using logistic regression, and continuous variables were imputed using predictive means matching.

Attrition Weights {#s2.7}
-----------------

To address the potential for bias due to nonrandom attrition over time in leukocyte count analyses in WHI and ARIC, stabilized inverse probability weights for each participant were calculated at each examination using logistic regression, where the numerator was the marginal probability of the participant not being lost to follow-up at an examination and the denominator was the probability of the participant not being lost to follow-up at an examination conditional on their covariate patterns at prior examination ([@c44]).

Statistical Analysis: Leukocyte Count {#s2.8}
-------------------------------------

Study- and center-stratified, PM--leukocyte count associations were estimated using an attrition-weighted and covariate-adjusted, two-level, linear, mixed-effects, longitudinal model including a random intercept for examination at the participant level. The model was given by $$LC_{ij} = \beta_{0} + \beta_{1}PM_{ij} + \beta_{2}Z_{ij} + b_{0j}^{P} + \varepsilon_{ij}^{E},$$where *i* and *j* denote the *i*th examination (level 1) of the *j*th participant (level 2); *LC* is the leukocyte count; $\beta_{0}$ is the intercept; *PM* is the 2- or 7-d mean of ${PM}_{10}$ or the 1- or 12-month mean of ${PM}_{2.5}$, ${PM}_{10}$, or ${PM}_{2.5–10}$; and *Z* is a vector of covariates. The term $\left( b_{0}^{P} \right) \sim N\left( {0,G} \right)$ is a random intercept for examination at the participant level to account for within-participant variation, and $\varepsilon^{E} \sim \left( {0,\sigma^{2}} \right)$ is the random error at the examination level. Study- and center-specific measures of association ($\beta_{1}$) and their 95% confidence intervals (CIs) were estimated as $\beta_{1} \pm 1.96 \times \text{the\  \ standard\  \ error\  }\left( \text{SE} \right)$ per $10{\text{-}\mu g/m}^{3}$ increase in PM, forest plotted, and pooled in random-effects meta-analyses ([@c24]) after testing homogeneity of associations among strata ($p_{\text{Cochran}’s\, Q} < 0.10$) ([@c21]).

Statistical Analysis: Leukocyte Composition {#s2.9}
-------------------------------------------

Subpopulation-stratified, cross-sectional, PM--leukocyte proportion associations were analyzed using multivariate methods for compositional data ([@c2]; [@c30]), that is, a set of positive, mutually exclusive components (such as proportions, *p*) that represent parts constituting a whole, are multicollinear, and collectively sum to 1 within a constrained space called a simplex. Proportions were isometrically log-ratio (ilr)-transformed from the simplex to real (Euclidean geometric) space. Transformation---which allowed for the dependent variation ([@c16]; [@c30]) and relative positioning of components in the simplex ([@c16]; [@c33])---resulted in *p*-1 orthogonal (i.e., non-multicollinear) coordinates. It also allowed for back-transformation of multivariate results into component proportions ([@c72]). Back-transformation was based on compositional data analysis models, as given by $$ilr\left( {LP} \right) = \beta_{0} + \beta_{1}PM + \beta_{3}Z + \varepsilon,$$where $ilr\left( {LP} \right)$ denotes the ilr-transformed estimated leukocyte proportions; $\beta_{0}$ is the intercept; *PM* is the 2- or 7-d mean of ${PM}_{10}$ or the 1- or 12-month mean of ${PM}_{2.5}$, ${PM}_{10}$, or ${PM}_{2.5–10}$; *Z* is a vector of covariates; and $\varepsilon \sim \left( {0,\sigma^{2}} \right)$ is the random error term. The vector of association measures ($\beta_{1}$) denotes the five orthogonal coordinates, the back-transformation of which represents the corresponding difference in each of the six leukocyte proportions per $10{\text{-}\mu g/m}^{3}$ increase in PM. Because the SEs of $\beta_{1}$ cannot be back-transformed, the SEs of back-transformed leukocyte proportion associations were estimated using 1,000 bootstrap samples. Subpopulation-specific measures of association were reported as absolute percentage differences (%), forest plotted, and pooled in random effects meta-analyses ([@c24]) after testing homogeneity of associations among strata ($p_{\text{Cochran}’s\, Q} < 0.10$) ([@c21]).

Statistical Analysis: Sensitivity {#s2.10}
---------------------------------

In leukocyte count analyses, Model 1 adjusted for self-identified race/ethnicity, age, sex (in ARIC), randomly assigned treatment group (in WHI), visit, mean temperature, mean dew point, mean barometric pressure, season (to control for within-year variation), and a restricted cubic natural spline function of calendar date ([@c9]; [@c28]; [@c73]) with one knot per year to control for secular trends in PM and leukocyte count methods. Model 2 also adjusted for potential socioeconomic confounders (individual-level education and neighborhood socioeconomic status). Model 3 additionally adjusted for behavioral variables that explain variation in leukocyte traits or account for residual confounding (smoking status, alcohol use, BMI, and physical activity). The sensitivity of Model 3 results to the use of two knots per calendar year, one knot for every two calendar years, and no calendar date adjustment was assessed. Although leukocyte composition analyses also adjusted for subpopulation-specific covariates, the models did not adjust for calendar date because leukocyte proportions were estimated using the same methods across subpopulations. In addition, leukocyte composition models were not center-stratified due to small sample sizes and instead were adjusted for U.S. Census region (Midwest, Northeast, South, and West). Sensitivity of leukocyte count associations to PM estimation method was examined by substituting spatially estimated 28- and 365-d mean concentrations of ${PM}_{10}$ for spatiotemporally estimated 1- and 12-month mean concentrations of ${PM}_{10}$. Sensitivity of significant PM-estimated leukocyte composition associations were assessed in a subset of ARIC participants with available measured leukocyte composition data (lymphocyte, monocyte, and granulocyte proportions). Additional sensitivity of PM--leukocyte composition associations were evaluated by estimating PM associations with the log-transformed ratio of $\text{CD}4^{+}$ to $\text{CD}8^{+}$ T-cell proportions (CD4:CD8)---a marker of immune function and possible biomarker for coronary heart disease ([@c66]). PM--CD4:CD8 associations were reported as percentage changes.

Results {#s3}
=======

Of the 150,328 WHI participants and 15,347 ARIC participants with leukocyte count data (total $n = 165,675$; [Figure 1](#f1){ref-type="fig"}), 96% and 94% had baseline data after exclusions. At baseline, participants were 62.3 years of age on average and mostly female (96%), white (84%), more than high school educated (74%), never/former smokers (91%), and current alcohol users (70%). Mean BMI, physical activity, and leukocyte count were $28.0{\,{kg}/m}^{2}$, 12.3 MET-hours/week, and $5,908\text{ \ cells}/\mu L$ ([Table 1](#t1){ref-type="table"}). Participants in the WHI and ARIC subpopulations with leukocyte composition data ($n = 8,457$; Table S2) were more likely to be younger (mean age: 61.5 y) and male (16%) and less likely to be white (45%), more than high school educated (52%), never/former smokers (85%), and current alcohol users (52%) than those with leukocyte count data. Among these subpopulations, mean estimated leukocyte cell type percentages were 9% ($\text{CD}8^{+}$ T cells), 18% ($\text{CD}4^{+}$ T cells), 7% (natural killer cells), 7% (B cells), 10% (monocytes), and 49% (granulocytes).

![Map of geocoded Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1986--1998) study participants and centers at baseline. WHI centers ($n = 39$) followed 1,238--3,690 participants. ARIC centers followed 3,588--3,943 participants. WHI and ARIC centers were co-located in Minneapolis, MN, and Winston-Salem, NC.](ehp-128-017004-g001){#f1}

Mean ${PM}_{10}$ concentrations in the populations with leukocyte count and composition data were below U.S. EPA National Ambient Air Quality Standards (NAAQS) in place during the study period (24-h ${PM}_{10} \leq 150{\,\mu g/m}^{3}$; annual ${PM}_{10} \leq 50{\,\mu g/m}^{3}$) ([@c98]). However, 1- and 12-month mean ${PM}_{2.5}$ concentrations in ARIC approached or exceeded the annual standard in place during the study period ($\leq 15{\,\mu g/m}^{3}$) ([Table 2](#t2){ref-type="table"}; Table S3). ${PM}_{10}$ and ${PM}_{2.5}$ concentrations were higher, whereas ${PM}_{2.5–10}$ concentrations were lower among subpopulations with leukocyte composition data.

###### 

$\text{Mean} \pm \text{standard\  \ deviation\  }\left( \text{SD} \right)$ Particulate matter concentrations among $n = 165,675$ participants with leukocyte count data before imputation, Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1986--1998) study.

Table 2 has the following nine columns: PM micrograms per cubic meter; WHI screening visit and ARIC visit 1 (n equals 159,162); WHI screening visit (n equals 144,744); WHI annual visit 3 (n equals 77,096); ARIC visit 1 (n equals 14,418); ARIC visit 2 (n equals 13,000); ARIC visit 3 (n equals 3,100); ARIC visit 4 (n equals 5,433); and WHI and ARIC percentage imputed of 285,548 observations.

  PM (${\mu g/m}^{3}$)   WHI screening visit and ARIC visit 1 $n = 159,162$   WHI               ARIC              WHI and ARIC                                                            
  ---------------------- ---------------------------------------------------- ----------------- ----------------- ----------------- ----------------- ----------------- ----------------- -----
  ${PM}_{10}$                                                                                                                                                                             
   2-d                   $29.5 \pm 11.9$                                      $28.4 \pm 11.1$   $28.4 \pm 11.2$   $39.8 \pm 14.1$   $35.4 \pm 12.3$   $31.9 \pm 11.9$   $28.2 \pm 10.1$   5.5
   7-d                   $28.7 \pm 9.3$                                       $27.6 \pm 8.3$    $27.6 \pm 8.6$    $39.2 \pm 10.3$   $34.4 \pm 8.5$    $30.9 \pm 8.1$    $27.4 \pm 7.4$    5.5
   1-month               $20.9 \pm 6.7$                                       $20.6 \pm 6.6$    $20.6 \pm 6.6$    $25.2 \pm 7.1$    $22.0 \pm 5.7$    $24.3 \pm 6.5$    $21.2 \pm 5.4$    7.0
   12-month              $20.9 \pm 5.1$                                       $20.8 \pm 5.1$    $20.7 \pm 5.0$    $24.4 \pm 4.4$    $22.6 \pm 3.8$    $23.4 \pm 2.6$    $21.1 \pm 2.1$    8.9
  ${PM}_{2.5}$                                                                                                                                                                            
   1-month               $12.2 \pm 4.3$                                       $12.0 \pm 4.1$    $12.0 \pm 4.2$    $15.2 \pm 5.2$    $13.6 \pm 4.2$    $15.2 \pm 4.2$    $15.2 \pm 4.0$    7.0
   12-month              $12.1 \pm 3.0$                                       $12.0 \pm 3.0$    $12.0 \pm 2.9$    $14.7 \pm 3.6$    $13.8 \pm 3.2$    $14.9 \pm 1.4$    $14.8 \pm 1.3$    8.9
  ${PM}_{2.5–10}$                                                                                                                                                                         
   1-month               $8.7 \pm 4.7$                                        $8.6 \pm 4.8$     $8.6 \pm 4.8$     $10.0 \pm 3.4$    $8.4 \pm 2.7$     $9.0 \pm 3.0$     $6.0 \pm 2.5$     7.0
   12-month              $8.7 \pm 3.9$                                        $8.7 \pm 4.0$     $8.7 \pm 4.0$     $9.7 \pm 2.1$     $8.8 \pm 1.7$     $8.5 \pm 1.5$     $6.2 \pm 1.7$     8.9

Note: ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; PM, particulate matter; ${PM}_{10}$, ${PM} \leq 10\;\mu m$ in diameter; ${PM}_{2.5}$, ${PM} \leq 2.5\;\mu m$ in diameter; ${PM}_{2.5–10}$, ${PM} > 2.5$ and $< 10\;\mu m$ in diameter; WHI, Women's Health Initiative.

WHI Observational Study participants only.

Participants from Washington County only.

Participants from Forsyth County (46%) or Washington County (54%).

In Models 1--3, short-term mean ${PM}_{10}$ concentrations were inversely associated with leukocyte count when pooled across study- and center-specific strata. For example, in Model 3, there were 7 (95% CI: $- 13$, $- 1$) and 11 ($- 20$, $- 2$) $\text{cells}/\mu L$ lower leukocyte counts per $10{\text{-}\mu g/m}^{3}$ increase in 2- and 7-d mean ${PM}_{10}$ concentration ([Table 3](#t3){ref-type="table"}; [Figure 2](#f2){ref-type="fig"}).

###### 

Pooled difference in leukocyte count ($\Delta$; $\text{cells}/\mu L$) per $10{\text{-}\mu g/m}^{3}$ increase in PM concentrations among $n = 165,675$ participants, Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1986--1998) study.

Table 3 has seven columns. The first column lists per day mean and mentioning the value as PM subscript 10 microgram per cubic meter. The adjacent columns list delta 95 percent C I cells per microliter and P subscript Cochran's Q for model 1, model 2, and model 3.

  PM exposure                         Model 1[^*a*^](#TF11){ref-type="table-fn"}   Model 2[^*b*^](#TF12){ref-type="table-fn"}   Model 3[^*c*^](#TF13){ref-type="table-fn"}                                   
  ----------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- ------ ------------------------ ------
  ${PM}_{10}$ (${\mu g/m}^{3}$)                                                                                                                                                                              
   2-d mean                           $- 6$ ($- 12$, 0)                            0.89                                         $- 7$ ($- 12$, $- 1$)                        0.90   $- 7$ ($- 13$, $- 1$)    0.91
   7-d mean                           $- 10$ ($- 19$, $- 1$)                       0.49                                         $- 10$ ($- 20$, $- 1$)                       0.53   $- 11$ ($- 20$, $- 2$)   0.42
   1-month mean                       22 ( 3, 41)                                  2.5$\times 10^{–3}$                          8 ($- 8$, 25)                                0.08   $- 2$ ($- 18$, 14)       0.08
   12-month mean                      65 (26, 103)                                 6.5$\times 10^{–4}$                          32 (4, 59)                                   0.37   8 ($- 17$, 33)           0.56
  ${PM}_{2.5}$ (${\mu g/m}^{3}$)                                                                                                                                                                             
   1-month mean                       33 (9, 56)                                   0.21                                         21 (0, 43)                                   0.51   12 ($- 9$, 33)           0.45
   12-month mean                      114 (65, 163)                                0.59                                         64 (15, 114)                                 0.99   28 ($- 20$, 75)          0.99
  ${PM}_{2.5–10}$ (${\mu g/m}^{3}$)                                                                                                                                                                          
   1-month mean                       18 ($- 8$, 44)                               0.01                                         $- 1$ ($- 24$, 21)                           0.13   $- 13$ ($- 36$, 9)       0.12
   12-month mean                      67 (8, 127)                                  6.5$\times 10^{–6}$                          18 ($- 30$, 66)                              0.04   $- 5$ ($- 47$, 36)       0.15

Note: ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; PM, particulate matter; ${PM}_{10}$, ${PM} \leq 10\;\mu m$ in diameter; ${PM}_{2.5}$, ${PM} \leq 2.5\;\mu m$ in diameter; ${PM}_{2.5–10}$, ${PM} > 2.5$ and $< 10\;\mu m$ in diameter; WHI, Women's Health Initiative.

Model 1 adjusted for race/ethnicity, age, sex (in ARIC), randomly assigned treatment group (in WHI), mean temperature, mean dew point, mean barometric pressure, season, and a restricted cubic natural spline function of calendar time with one knot per calendar year.

Model 2 adjusted for all covariates in Model 1 and additionally for individual-level education and neighborhood socioeconomic status.

Model 3 adjusted for all covariates in Model 2 and additionally for smoking status, alcohol use, body mass index, and physical activity.

Homogeneity of associations among strata was tested using Cochran's *Q*-test statistic, where a $p_{\text{Cochran}’s\, Q} < 0.10$ suggests there is evidence to reject the null hypothesis of homogeneity.

![Pooled difference in leukocyte count ($\Delta$; $\text{cells}/\mu L$) per $10{\text{-}\mu g/m}^{3}$ increase in PM concentrations among $n = 165,675$ participants, Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1986--1998) study. Model 1 adjusted for race/ethnicity, age, sex (in ARIC), randomly assigned treatment group (in WHI), mean temperature, mean dew point, mean barometric pressure, season, and a restricted cubic natural spline function of calendar date with one knot per year. Model 2 adjusted for all covariates in Model 1 plus individual-level education and neighborhood socioeconomic status. Model 3 adjusted for all covariates in Model 2 plus smoking status, alcohol use, body mass index, and physical activity.](ehp-128-017004-g002){#f2}

In Model 1, longer-term mean ${PM}_{10}$, ${PM}_{2.5}$, and ${PM}_{2.5–10}$ concentrations were positively, but imprecisely, associated with the leukocyte count (i.e., they had wide CIs). However, the associations also were attenuated by additional adjustment for potential socioeconomic confounders (Model 2) and behavioral variables (Model 3). For example, there were 114 (65, 163), 64 (15, 114), and 28 ($- 20$, 75) $\text{cells}/\mu L$ higher leukocyte counts per $10{\text{-}\mu g/m}^{3}$ increase in the 12-month mean ${PM}_{2.5}$ concentration in Models 1--3 ([Table 3](#t3){ref-type="table"}; Figure S2). In sensitivity analyses, estimates were generally robust to variation in the method of controlling for calendar date (see Figure S3). Leukocyte count associations with 28- and 365-d mean ${PM}_{10}$ concentrations also were imprecise and no different from the null associations (see Table S4), as those between leukocyte count and 1- and 12-month mean ${PM}_{10}$.

Across PM size fractions and averaging durations, PM--leukocyte compositional associations in Model 3 ([Table 4](#t4){ref-type="table"}) differed little from those in Models 1 and 2 (see Tables S5--S6). Higher 7-d mean ${PM}_{10}$ concentrations were associated with somewhat higher $\text{CD}8^{+}$ T-cell proportions, whereas 1- and 12-month mean ${PM}_{10}$ concentrations were associated with somewhat lower $\text{CD}8^{+}$ T-cell proportions ([Table 4](#t4){ref-type="table"}; Figure S4). One- and 12-month mean concentrations of ${PM}_{2.5}$ were associated with lower $\text{CD}8^{+}$ T-cell, NK cell, and B-cell proportions and higher granulocyte proportions. For example, there was a 1.1% ($- 1.9\%$, $- 0.3\%$) lower $\text{CD}8^{+}$ T-cell proportion and 1.2% (0.6%, 1.8%) higher granulocyte proportion per $10{\text{-}\mu g/m}^{3}$ increase in 1-month mean ${PM}_{2.5}$ ([Figure 3](#f3){ref-type="fig"}). In contrast, there were 0.6% ($- 1.3\%$, 0.1%) and 1.2% ($- 2.4\%$, 0.1%) lower granulocyte proportions per 1- and 12-month mean ${PM}_{2.5\text{−}10}$ (see Figure S4). ${PM}_{2.5}$ associations with estimated granulocyte proportions were consistent in magnitude and direction with those in the analyses of measured granulocyte proportions (see Table S7). PM--CD4:CD8 associations were generally inconsistent, with suggestively inverse associations with short-duration ${PM}_{10}$ and suggestively positive associations with longer duration ${PM}_{10}$ and ${PM}_{2.5}$; however, CIs were wide and included the null (Table S8).

###### 

Pooled difference in estimated leukocyte proportion ($\Delta$; %) per $10{\text{-}\mu g/m}^{3}$ increase in PM concentrations among $n = 8,457$ participants, Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1990--1995) study.

Table 4 has thirteen columns. The first column lists per day mean. The adjacent columns list delta 95 percent C I and P subscript Cochran's Q for CD8 positive T cells, CD4 positive T cells, natural killer cells. B cells, monocytes, and granulocytes.

  PM exposure                         $\text{CD}8^{+}$ T cells     $\text{CD}4^{+}$ T cells   Natural killer cells     B cells   Monocytes                Granulocytes                                                                                                
  ----------------------------------- ---------------------------- -------------------------- ------------------------ --------- ------------------------ -------------- ---------------------------- ------ ------------------------ ------ ------------------------ ------
  ${PM}_{10}$ (${\mu g/m}^{3}$)                                                                                                                                                                                                                                       
   2-d mean                           0.1 ($- 0.4$, 0.6)           0.15                       $- 0.1$ ($- 0.4$, 0.2)   0.12      0.0 ($- 0.2$, 0.3)       0.93           $- 0.2$ ($- 0.4$, 0.0)       0.46   0.0 ($- 0.1$, 0.2)       0.49   0.1 ($- 0.1$, 0.3)       0.69
   7-d mean                           0.3 ($- 0.3$, 0.8)           0.28                       $- 0.2$ ($- 0.5$, 0.1)   0.63      $- 0.1$ ($- 0.6$, 0.4)   0.18           $- 0.4$ ($- 0.7$, $- 0.1$)   0.93   $- 0.1$ ($- 0.3$, 0.2)   0.49   $- 0.2$ ($- 0.5$, 0.2)   0.25
   1-month mean                       $- 0.4$ ($- 1.2$, 0.3)       0.30                       0.0 ($- 0.5$, 0.5)       0.26      $- 0.3$ ($- 1.0$, 0.4)   0.16           $- 0.2$ ($- 0.7$, 0.2)       0.64   0.2 ($- 0.4$, 0.8)       0.06   0.4 ($- 0.1$, 0.9)       0.28
   12-month mean                      $- 0.5$ ($- 1.4$, 0.4)       0.63                       0.1 ($- 0.5$, 0.6)       0.38      $- 0.3$ ($- 1.5$, 0.8)   0.14           $- 0.5$ ($- 1.1$, 0.2)       0.58   $- 0.3$ ($- 0.7$, 0.1)   0.41   0.0 ($- 0.9$, 1.0)       0.13
  ${PM}_{2.5}$ (${\mu g/m}^{3}$)                                                                                                                                                                                                                                      
   1-month mean                       $- 1.1$ ($- 1.9$, $- 0.3$)   0.58                       $- 0.2$ ($- 1.0$, 0.6)   0.18      $- 0.6$ ($- 2.2$, 1.0)   0.00           $- 0.5$ ($- 1.1$, 0.1)       0.72   $- 0.1$ ($- 0.5$, 0.3)   0.44   1.2 (0.6, 1.8)           0.75
   12-month mean                      $- 1.3$ ($- 2.4$, $- 0.1$)   0.84                       0.2 ($- 0.7$, 1.2)       0.34      $- 1.4$ ($- 3.7$, 0.8)   0.03           $- 0.9$ ($- 1.9$, 0.2)       0.42   $- 0.4$ ($- 0.9$, 0.2)   0.65   1.1 ($- 0.2$, 2.4)       0.25
  ${PM}_{2.5–10}$ (${\mu g/m}^{3}$)                                                                                                                                                                                                                                   
   1-month mean                       0.5 ($- 0.9$, 1.8)           0.23                       0.0 ($- 0.6$, 0.6)       0.80      $- 0.1$ ($- 0.8$, 0.7)   0.63           $- 0.2$ ($- 0.9$, 0.5)       0.80   0.1 ($- 0.7$, 0.8)       0.14   $- 0.6$ ($- 1.3$, 0.1)   0.33
   12-month mean                      0.0 ($- 2.4$, 2.3)           0.13                       $- 0.2$ ($- 1.0$, 0.6)   0.51      0.3 ($- 0.9$, 1.4)       0.80           $- 0.3$ ($- 1.3$, 0.7)       0.71   $- 0.2$ ($- 0.9$, 0.4)   0.60   $- 1.2$ ($- 2.4$, 0.1)   0.17

Note: ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; PM, particulate matter; ${PM}_{10}$, ${PM} \leq 10\;\mu m$ in diameter; ${PM}_{2.5}$, ${PM} \leq 2.5\;\mu m$ in diameter; ${PM}_{2.5–10}$, ${PM} > 2.5$ and $< 10\;\mu m$ in diameter; WHI, Women's Health Initiative.

Model adjusted for race/ethnicity, age, sex (in ARIC), randomly assigned treatment group (in WHI), mean temperature, mean dew point, mean barometric pressure, season, individual-level education, neighborhood socioeconomic status, smoking status, alcohol use, body mass index and physical activity.

Homogeneity of associations among strata was tested using the Cochran's *Q*-test statistic, where a $p_{\text{Cochran}’s\, Q} < 0.10$ suggests there is evidence to reject the null hypothesis of homogeneity.

![Pooled difference in leukocyte composition ($\Delta$; %) per $10{\text{-}\mu g/m}^{3}$ increase in (A) 1- and (B) 12-month mean ${PM}_{2.5}$ concentrations among $n = 8,457$ participants, Women's Health Initiative (1993--2002) and Atherosclerosis Risk in Communities (1990--1995) study. Model 1 adjusted for race/ethnicity, age, sex (in ARIC), randomly assigned treatment group (in WHI), mean temperature, mean dew point, mean barometric pressure, season, and subpopulation-specific covariates. Model 2 also adjusted for individual-level education and neighborhood socioeconomic status. Model 3 additionally adjusted for smoking status, alcohol use, body mass index, and physical activity.](ehp-128-017004-g003){#f3}

Discussion {#s4}
==========

Results from this study suggest that mid- to longer-duration exposures to ${PM}_{2.5}$ concentrations below U.S. EPA NAAQS may be associated with a higher leukocyte count, higher granulocyte proportion, and lower $\text{CD}8^{+}$ T-cell proportion among multi-ethnic and geographically diverse populations of U.S. women and men.

Although leukocyte count associations were also observed with 1- and 12-month mean ${PM}_{10}$ and ${PM}_{2.5–10}$ concentrations, adjusting for potential socioeconomic confounders attenuated them. Indeed, lower socioeconomic status has been related both to increases in CVD risk ([@c31]) and higher concentrations of ambient PM ([@c40]). Further attenuation was observed with additional adjustment for behavioral variables (smoking, alcohol use, BMI, and physical activity) suggesting that they may account for residual confounding by socioeconomic or other unmeasured characteristics. Taken together with prior evidence suggesting positive ([@c17]) and null ([@c102]) associations between longer-duration ${PM}_{10}$ with leukocyte counts, the present results were unable to clarify the relationship. Nevertheless, positive---yet imprecise---leukocyte count estimates remained for ${PM}_{2.5}$, supporting evidence first reported in the Heinz Nixdorf Recall study ([@c102]). Moreover, the magnitudes of estimates presently observed are on par with those previously associated with a 1-cigarette/d increase in smoking ([@c41]; [@c75]; [@c86]).

${PM}_{2.5}$ concentrations were also associated with leukocyte composition; particularly, with higher granulocyte and lower $\text{CD}8^{+}$ T-cell proportions. This observation is consistent with results from the Social Environment and Biomarkers of Aging Study (SEBAS) in Taiwan that found positive associations between long-duration ${PM}_{2.5}$ exposure and the proportion of neutrophils, the most abundant type of granulocyte ([@c20]). SEBAS also detected similar associations with long-duration ${PM}_{10}$ concentrations, but they were not observed in the present study. Results are also consistent with small-scale occupational studies that found higher neutrophil ([@c79]) and lower lymphocyte/$\text{CD}8^{+}$ T-cell proportions ([@c79]; [@c110]) albeit with short-duration exposure to ${PM}_{2.5}$, which was further demonstrated in rats ([@c34]; [@c37]; [@c50]). Indeed, observed lower $\text{CD}8^{+}$ T-cell proportions may be related to PM-responsive migration of $\text{CD}8^{+}$ lymphocytes from the blood to bronchial tissues ([@c83]), contraction of the $\text{CD}8^{+}$ regulatory (suppressor) T-cell pool, and/or latter phase homeostatic contraction of the $\text{CD}8^{+}$ cytotoxic T-cell pool ([@c45]).

Persistent systemic inflammation due to longer-duration PM exposure is a biologically plausible mechanism linking PM with adverse health. Indeed, systemic inflammation has been implicated in endothelial injury, atherosclerotic disease progression, and subsequent increases in CVD risk ([@c80]). In the epidemiologic context, systemic inflammation, as measured by leukocyte count, has been consistently and independently associated with CVD and mortality in WHI ([@c49]; [@c59]), in ARIC ([@c53]), and in other populations ([@c15]; [@c23]; [@c82]).

The results presented herein support the hypothesis that chronic exposure to PM contributes to systemic inflammation and may partly explain the established connection between PM and CVD risk ([@c18]; [@c61]). They support prior studies that mechanistically linked atherosclerosis and the inflammatory responses to PM ([@c1]; [@c12]; [@c26]; [@c52]; [@c74]). Such studies observed higher pro-inflammatory cytokines following inhalation and deposition of PM in the lungs ([@c76]; [@c92]; [@c94], [@c95]; [@c99]) and the activation of coagulation and adhesion molecules ([@c7]; [@c11]; [@c68]; [@c76]; [@c81]; [@c97]), which could ultimately lead to increased leukocyte content within and vulnerability to rupture of atherosclerotic plaques ([@c12]; [@c57]; [@c80]).

Although the inverse relationship between short-duration (i.e., 2- and 7-d mean) ambient ${PM}_{10}$ exposures and leukocyte counts may be at odds with this suggestion, PM exposure may initiate pulmonary alveolar microvascular sequestration of monocytes and granulocytes ([@c38]; [@c93]; [@c108]), thereby reducing their concentrations in peripheral blood over the short term ([@c35]; [@c108]). Animal studies of monocytes and acute ${PM}_{10}$ exposure also suggest that atherosclerotic plaques may recruit leukocytes from the circulation ([@c108]). The inverse ${PM}_{10}$--leukocyte count associations with short-duration exposure in the present study are in contrast to null ([@c54]; [@c87]) and positive ([@c85]; [@c89]) epidemiologic associations observed in other contexts. However, they are consistent with observed inverse associations with short-duration exposure to ${PM}_{2.5}$ in the Normative Aging Study ([@c109]).

The characterization of PM--leukocyte associations in the compositional context is particularly relevant given the increasing availability of epigenomic biomarkers that are based on DNA extracted from peripheral blood with leukocyte proportions that can vary widely among participants. However, leukocyte cell types possess distinguishing patterns of DNAm, so measurements of methylation are driven in part by leukocyte composition ([@c48]). Common practice is therefore to restrict measurement of DNAm to a single cell type ([@c19]), to statistically adjust associations with DNAm for leukocyte proportions determined via cytometry as part of a complete blood count/differential, or in its absence, to adjust for DNAm-based estimates of $\text{CD}8^{+}$ T-cell, $\text{CD}4^{+}$ T-cell, NK cell, B-cell, monocyte, and granulocyte proportions ([@c43]; [@c69]). Mindful of the PM--leukocyte compositional associations detected herein, causal diagrams ([@c39]) may benefit from thoughtful consideration of their potential effects on causal association and mediation analyses ([@c100]; [@c101]) involving DNAm and other leukocyte-derived biomarkers. Indeed, leukocyte composition may itself be a mediator of PM--DNAm associations. As such, DNAm associations with ${PM}_{2.5}$---without control for leukocyte composition---may reflect mechanisms that involve inflammation, epigenetics, or both.

The present results are nevertheless limited by the variances of the observed association estimates. The analyses were weighted for attrition to avoid potential selection bias due to nonrandom loss to follow-up; however, the loss of bias came at the cost of precision ([@c22]). Furthermore, precision was influenced by technical, temporal, and biological variation of leukocyte count measurements. Participant blood samples were collected, processed, and analyzed by local laboratories across the United States using different automated hematology cell counters. Indeed, secular trends in methods of determining leukocyte count ([@c82]) may have affected the precision or accuracy of association estimates. And while lack of adjustment for other cell (e.g., erythrocyte, platelet) counts capable of explaining some variation in leukocyte counts may have contributed to the precision of estimates observed herein, there also is evidence to suggest high within-laboratory reliability of leukocyte counts ([@c67]) and robustness of study- and center-stratified, longitudinal model results to multiple methods of calendar date adjustment. Moreover, erythrocyte and platelet counts---plausible intermediates of PM--leukocyte count associations---were neither uniformly available nor necessarily appropriate candidates for statistical adjustment ([@c84]).

Additional limitations include error in estimated leukocyte proportions and PM concentrations. Although cytometrically determined leukocyte proportions for the cell types of interest were not available herein at participant visits with corresponding PM data, estimation of the $\text{CD}8^{+}$ T-cell, $\text{CD}4^{+}$ T-cell, NK cell, B-cell, monocyte, and granulocyte proportions at hand was associated with a low root mean square error (median rMSE: 8.2%, range: 5.4--11.6%) ([@c43]; [@c51]). Furthermore, the validity of spatially estimated daily ${PM}_{10}$ estimates was demonstrated with an average prediction error and standardized prediction error near zero, a root mean square standardized near one, and a root mean square prediction error near the SE ([@c55], [@c56]). Similarly, models for spatiotemporally estimated monthly mean ${PM}_{10}$ and ${PM}_{2.5}$ estimation performed well, with high squared Pearson correlations between excluded monthly observations and model predictions ($R^{2} = 0.68–0.77$) in a 5- to 10-fold, out-of-sample cross-validation ([@c107]). Therefore, outcome and exposure measurement error were less likely to have biased observed associations.

Limitations aside, this longitudinal study observed that 1- and 12-month mean ambient ${PM}_{2.5}$ concentrations were associated with higher leukocyte count. It is the first to do so in large, multi-ethnic and geographically diverse populations of women and men from two well-characterized cardiovascular disease cohorts. Furthermore, this study is the first to use compositional data analysis methods to estimate associations between ambient ${PM}_{2.5}$ concentrations and leukocyte composition. Its analyses accounted for known relationships among proportions, thereby avoiding methodological biases inherent in conventional analyses that erroneously assume compositional data are independent. Results from them are therefore relatively well positioned to inform future causal analyses using leukocyte-derived biomarkers.

In conclusion, findings suggest that mid- to longer-duration ambient exposure to fine particulate matter (${PM}_{2.5}$) air pollution may induce subclinical, but epidemiologically important, inflammatory responses among racially, ethnically, and environmentally diverse U.S. populations in U.S. EPA Regions 1--10.
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